- ZEVASKYN is the only FDA-approved therapy to treat RDEB wounds with a single application - ...

Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western Technology played a key role in supporting ...

Bio-Techne Corporation (NASDAQ: TECH) today announced that its Simple Western™ Technology played a key role in ...

The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with advanced pulmonary arterial hypertension, according to a press release ...

Thousands of pounds of organic blueberries are being recalled because they may be contaminated with listeria bacteria. FDA gives highest risk warning.

In April 2025, prademagene zamikeracel (Zevaskyn, Abeona Therapeutics) became the first FDA-approved cell-based genetic therapy when it was approved for the treatment of wounds in adult and ...

Abeona was awarded the PRV by the U.S. Food and Drug Administration (FDA) in April 2025 in connection with the FDA’s approval of ZEVASKYN™ (prademagene zamikeracel), the first and only U.S. approved ...

The FDA issued a Class I risk level for a recall of 12,000 pounds of organic blueberries due to possible listeria contamination.

Abeona was awarded the PRV by the U.S. Food and Drug Administration (FDA) in April 2025 in connection with the FDA’s approval of ZEVASKYN™ (prademagene zamikeracel), the first and only U.S ...